跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BioBerb (LipiSperse Berberine) 188mg Capsule - TGA Drug Approval Details
Approvals
/
TGA
/
BioBerb (LipiSperse Berberine) 188mg Capsule
Approved
STANDARD
BioBerb (LipiSperse Berberine) 188mg Capsule
Pharmako Biotechnologies Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
201edea514c9ab63
Company
Pharmako Biotechnologies Pty Ltd
Type
Standard
Approval Details
Approval Id
201edea514c9ab63
Product Name
BioBerb (LipiSperse Berberine) 188mg Capsule
Artg Id
460810
Artg Name
BioBerb (LipiSperse Berberine) 188mg Capsule
Sponsor
Pharmako Biotechnologies Pty Ltd
Company Detail Path
/organization/pharmako-biotechnologies-pty-limited
Artg Date
2024-08-27
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LI
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
201edea514c9ab63
Type
Standard
Back to TGA Approvals
